BCYRN1 and non-small cell lung carcinoma: A study of non-small cell lung cancer cell lines reports a reduction in cell migration/invasion upon BC200 knock-down [9], and CRISPR/Cas9 knock-out of BC200 in MCF-7 cells showed reduced viability, altered morphology and susceptibility to apoptosis [10].